OMC Stocks IOC BPCL HPCL in Focus After Third Fuel Price Hike in Eight Days Hiring Landscape Shifts Skills Over Diplomas in EntryLevel Recruitment David Einhorns Hedge Fund Greenlight Capital Takes Bullish Stance on Major Mall Retail Stock Indian Equity Indices Edge Higher Sensex Gains 230 Points Nifty 50 Closes Above 23700 as Banking Stocks Outperform Bitcoin 2022 Price Pattern Resurfaces as Second Downturn Deepens Trump Skips Son Donald Jrs Wedding Amid Family Health Disclosures CPNG Q1 2026 Earnings EPS Misses by Over 200 Amid Strategic Investments Shares Rise 277 ALGT Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discontinuation Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported ZION Q1 2026 Earnings EPS Surpasses Estimates by Over 7 Amid Solid Operating Performance UZD Q1 2026 Earnings EPS Surges Past Estimates by Nearly 90 as Digital Infrastructure Demand Accelerates Flowserve Corporation FLS Q1 2026 Earnings EPS Surprise Beats Estimates Amid Operational Discipline TeraWulf Inc WULF Holds Near Resistance as Digital Infrastructure Demand Drives Modest Gains Voyager Therapeutics VYGR Shares Rebound 476 as Biotech Sector Shows Strength Valneva Shares Edge Higher as Price Action Tests Key Resistance Levels Dycom Industries DY Nears Support After Modest Decline Cross Timbers Royalty Trust CRT Surges 272 Key Levels to Watch Sothebys Thwarts Attempt to Sell Counterfeit Ancient Artifacts Fraud Case Highlights Due Diligence in Art Market Symbotic Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Growth Optimism Intercorp Financial Services IFS Declines 123 as Key Support Levels Come into Focus IMPPP Q1 2026 Earnings Strong EPS Surprise of 644 Exceeds Expectations InspireMD NSPR Q1 2026 Earnings EPS Beat Despite Net Loss Shares Dip 29 LaZBoy LZB Q1 2026 Earnings EPS Falls Short Stock Holds Steady Amid Investor Patience DIBS Q1 2026 Earnings EPS Beats Estimates Stock Rises 337 RKT Q1 2026 Earnings EPS Surpasses Expectations Despite Stock Decline Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline ALLT Q1 2026 Earnings EPS Surprises to the Upside Amid Strong Operational Performance